Renaissance of “food as medicine” in modern clinical trials

Priya Venkatesan discusses in Nature Medicine how dietary interventions can prevent or delay diseases, highlighting the reemergence of “food as medicine” in modern clinical trials.

Time-restricted eating shows promising weight and metabolic benefits, study reveals

A comprehensive meta-analysis of RCTs suggests meal timing strategies, such as time-restricted eating, offer moderate weight loss benefits and improved metabolic outcomes. However, evidence quality

November 12, 2024

Denosumab biosimilar by Celltrion for Osteoporosis: Likelihood of Approval

Denosumab biosimilar is under clinical development by Celltrion and currently in Phase I for Osteoporosis.

March 19, 2024

Destruction of documents, insufficient data lead FDA to reject hep B vaccine update

Dynavax’s hepatitis B vaccine was rejected for a label expansion in the US after patient data was destroyed by a third-party clinical trial site operator,

May 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.